SPDL1 and neoplasm: Indeed, high levels of both sPD-1 and sPD-L1 forms have been detected in plasma/serum of different cancer patients, compared to healthy donors (HDs), and have been associated with tumor prognosis, therapeutic response and overall survival (OS) (32–37).